Article topic

News

Article

bit.bio featured in Forbes

The piece covers the launch of bit.bio's Custom ioDisease Model Cells at the SynBioBeta conference.

06.06.2023

Published by Forbes

The piece covers the launch of bit.bio's Custom ioDisease Model Cells at the SynBioBeta conference.

Published by Forbes

Read now

Article

Meet the company reprogramming the future of synthetic biology

SynbioBeta CEO John Cumbers talks reimagining cell therapies through cell reprogramming with Rick Klausner and bit.bio CEO.

13.04.2021

Published by Forbes

Read now

Article

Can we recreate every human cell type in the body? This UK startup thinks so

bit.bio and the London Institute of Mathematical Sciences (LIMS) want to recreate every human cell type.

13.11.2020

Published by Forbes

Read now

About us Coding cells to advance the wellbeing of humanity

Careers See the latest openings

Blog See the latest blogs

Related pages